Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/22/25 16:30 | 8/21/25 | SPRY | Health | Drug | Pharmaceutical Preparations | Lowenthal Richard E | CA | DOT | P,CEO | 1 | S | -724 | 14.49 | 0 | -50 | 0 | 11,303 | I | ||||||||||||||
8/22/25 16:30 | 8/21/25 | SPRY | Health | Drug | Pharmaceutical Preparations | Scott Kathleen D. | CA | O | CFO | 2 | M.d | 206 | 8.25 | 0 | 25 | 18 | D | |||||||||||||||
8/22/25 16:30 | 8/21/25 | SPRY | Health | Drug | Pharmaceutical Preparations | Scott Kathleen D. | CA | O | CFO | 2 | S.d | -206 | 8.25 | 0 | -25 | 18 | D | |||||||||||||||
8/21/25 17:36 | 8/19/25 | SPRY | Health | Drug | Pharmaceutical Preparations | Tanimoto Sarina | CA | OT | CHIEF ME | 1 | S.m | -704 | 14.08 | 0 | -50 | 0 | 11,353 | I | ||||||||||||||
7/3/25 16:21 | 7/1/25 | SPRY | Health | Drug | Pharmaceutical Preparations | Karas Eric | CA | O | Chief Co | 2 | M.d | 277 | 9.25 | 0 | 30 | 10 | D | |||||||||||||||
7/3/25 16:21 | 7/1/25 | SPRY | Health | Drug | Pharmaceutical Preparations | Karas Eric | CA | O | Chief Co | 2 | S.d | -277 | 9.25 | 0 | -30 | 10 | D | |||||||||||||||
7/1/25 16:42 | 6/27/25 | SPRY | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | T | 1 | S | -13,663 | 18.46 | 0 | -740 | 9,775 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |